NewslettersCell Therapy NewsGallic Acid Enhances Anti-lymphoma Function of Anti-CD19 CAR-T Cells In Vitro and In VivoBy Jamie Kang - March 6, 2023087Scientists explored combinatorial therapy by the use of anti-CD19 CAR-T immunotherapy and gallic acid for improving treatment efficacy.[Molecular Biomedicine]Full Article